At line 56 of page 5, it is indicated that patients were identified from 1 January 2014 to 31 December 2014. Should it be from 1 January 2011?
At lines 22-26 of page 6, the authors state that for years 2012 to 2014 incident cases were identified, however, these data are not reported in the results.
At line 6 of page 7, "hospital bed" means the hotel component of inpatient stay?
At page 6 I would add a reference to the conversion rate adopted.
In the statistical analysis section, authors state that prevalence was calculated each year on December 31. Do the UEBMI report the date of death of patients? Were patients died before the 31 December of each year excluded?
In the statistical analysis section at page 7, there are two closing round brackets, but the opening ones are missing.
Is there any patient in the analysis that was considered in two consecutive years? In this case, which age was considered in the analysis?
In table 1 is stated that the number of males covered is estimated, however in the methods it is stated that the number of males covered is derived from government official reports.
In the treatment costs section at page 9, authors should specify in the text to which year each economic import refers to.
In the headings of tables 4 and 5 the number of patients in brackets should be added for year 2014.
In the headings of table 5, "medication" is not pertinent. Furthermore, it is not clear to what the "bed" category refers to.
In the discussion section, authors should compare their results with those of similar context. Furthermore, authors state that "The proportion of bone metastasis among prostate cancer patients increased from 33.2% in 2011 to 47.5% in 2014, which is in line with other findings reporting a proportion of around 30%", however the second value is almost 50% higher than 30%.
In line 36 at page 13 I would avoid stating that "…patients spent money mainly on medication", reporting that "the highest cost component is that related to medications".
In line 40 at page 13 "greatest" should be substituted with "highest".
At line 15 of page 13 (Discussion), the reference 10 reported is the same indicated as reference 1. This should be corrected, modifying the numbers of all the following references.
In the abstract, manuscript and tables several numbers are reported without using commas to divide thousands. They should be added for consistency. The manuscript requires English language copy editing. The authors estimated the prevalence of metastatic (bone) prostate cancer among insured employees in Beijing between 2011 and 2014, along with direct medical costs. Data presented are of interests, however, the estimates cannot be extended outside the employed insured population of the city. There are issues that should be addressed as listed below.
REVIEWER
Comment 1: I suggest the authors to provide in the background a brief description of the Chinese Health System (i.e. based on social insurance schemes, etc…). This would help readers who are not familiar with it to better understand the whole paper.
Authors' response: We thank the reviewer for this comment and have now added some text in the Introduction of our revised manuscript to introduce the reader to the Chinese healthcare system. The more detailed description of the UEBMI database is contained in the 'Data source' section of the Methods.
Comment 2: As all direct medical costs seems to be reported in the UEBMI I would state it clearly in the objective and throughout the text (i.e. "the study aimed to assess the direct medical costs related to…"). Furthermore I would state clearly in the objective that the prevalence was estimated both for prostate cancer and prostate cancer with bone metastasis.
Authors' response: We acknowledge the reviewer's comment and have now changed the objective of our study stated at the end of our Introduction to read as follows: "Using an administrative claims database for employees in urban areas, we aimed to estimate the prevalence of all prostate cancer and of prostate cancer with bone metastasis, as well as associated direct medical costs among the male population of Beijing between 2011 and 2014." Comment 4: The perspective assumed in the economic analysis should be presented in the objective.
Authors' response: We thank the reviewer for this comment. The economic analysis was performed from a Chinese payer perspective, yet we do not think any reader will question this as it is implicit from the study design and setting. Therefore, we have not added it in the objective.
Comment 5: At line 45 of page 5 I would add "and" between "price of service" and "quantity of service".
Authors' response: We thank the reviewer for this comment and have now added 'and' in the relevant place as suggested.
Comment 6: At line 56 of page 5, it is indicated that patients were identified from 1 January 2014 to 31 December 2014. Should it be from 1 January 2011?
Authors' response: We thank the reviewer for noticing this error and have changed the text to read '…from 1 January 2011 to December 2014'.
Comment 7: At lines 22-26 of page 6, the authors state that for years 2012 to 2014 incident cases were identified, however, these data are not reported in the results.
Authors' response: We thank the reviewer for this comment. This text was added in error and does not belong to this study. We apologize for this and have now removed the text.
Comment 8: At line 6 of page 7, "hospital bed" means the hotel component of inpatient stay?
Authors' response: Yes, that is correct. To make this clearer to the reader, we have now changed the term 'hospital bed' to 'inpatient stay' (both in the 'Hospital visits and treatment costs' section of the Methods and in Table 5 ).
Comment 9: At page 6 I would add a reference to the conversion rate adopted.
Authors' response: We thank the reviewer for this comment and have now added the reference relating to the conversion rate applies -this was website of the People`s Bank of China, which is the central bank and a ministerial-level government agency in charge of commercial work of China.
Comment 10: In the statistical analysis section, the authors state that prevalence was calculated each year on December 31. Do the UEBMI report the date of death of patients? Were patients died before the 31 December of each year excluded?
Authors' response: We are grateful for the reviewers' very important comment. Unfortunately, because the date of death is not recorded in the UEBMI and the database is not linked to the city's death registry, we were unable to exclude patients who died before 31 December in each year in our analyses. We now refer to this as a limitation of our study in the Discussion of our revised manuscript.
Comment 11: In the statistical analysis section at page 7, there are two closing round brackets, but the opening ones are missing.
Authors' response: We thank the reviewer for noticing this editing error -this has now been amended.
Comment 12: Is there any patient in the analysis that was considered in two consecutive years? In this case, which age was considered in the analysis?
Authors' response: We thank the reviewer for this comment. Yes, patients who were enrolled in the database across study years would have been included in prevalence estimations for those years. When we refer to the age of patients we mean the average age of the patient at on the date of first recorded entry for bone metastasis in prostate cancer. We have revised the text in our manuscript to make this clearer for the reader.
Comment 13: In table 1 is stated that the number of males covered is estimated, however in the methods it is stated that the number of males covered is derived from government official reports.
Authors' response: We thank the reviewer for this comment. For our knowledge, the number of the male population reported from the government reports was based on the estimation. However, to make this clearer to the reader that the data was from the government report, we have removed the word 'estimated' from Table 1 for accuracy and consistency.
Comment 14: In the treatment costs section at page 9, authors should specify in the text to which year each economic import refers to.
Authors' response: We thank the reviewer for this comment and hope that the edited text in the section now makes the information clearer.
Comment 15: In the headings of tables 4 and 5 the number of patients in brackets should be added for year 2014.
Authors' response: We thank the reviewer for noticing this and have now added the number of patients for the year 2014 in brackets in these two tables.
Comment 16: In the headings of table 5, "medication" is not pertinent. Furthermore, it is not clear to what the "bed" category refers to.
Authors' response: We have now changed the heading of Table 5 to 'Diagnostic or therapeutic procedure' and have omitted the word 'medication', which as the reviewer rightly points out was incorrect. We have also changed the vague term 'bed' to 'inpatient stay' (please also refer to our response to Comment 8).
Comment 17: In the discussion section, authors should compare their results with those of similar context. Furthermore, authors state that "The proportion of bone metastasis among prostate cancer patients increased from 33.2% in 2011 to 47.5% in 2014, which is in line with other findings reporting a proportion of around 30%". However the second value is almost 50% higher than 30%.
Authors' response: We thank the reviewer for this comment and have removed the reference where we quote a proportion of around 30% as we realize that this reference was not appropriate. We have replaced the text with a discussion of other reported estimates, which are actually much lower than those in our study.
Comment 18: In line 36 at page 13 I would avoid stating that "…patients spent money mainly on medication", reporting that "the highest cost component is that related to medications".
Authors' response: We thank the reviewer for this comment and have edited this relevant sentence accordingly.
Comment 19: In line 40 at page 13 "greatest" should be substituted with "highest".
Authors' response: We have now changed the word 'greatest' with 'highest' as per the reviewer's sensible suggestion.
